First treatment, abnormal AST increase (42 days) · adults and children with uncomplicated P falciparum malaria
It is very uncertain whether pyronaridine‐artesunate (PY‐AS) changes first treatment, abnormal AST increase (42 days) compared with mefloquine plus artesunate (MQ + AS) (very low certainty).
1 finding from 1 review
First treatment, abnormal bilirubin increase (42 days) · adults and children with uncomplicated P falciparum malaria
It is very uncertain whether pyronaridine‐artesunate (PY‐AS) changes first treatment, abnormal bilirubin increase (42 days) compared with mefloquine plus artesunate (MQ + AS) (very low certainty).
1 finding from 1 review
Total failure: day 28 (unadjusted) · adults and children with uncomplicated P falciparum malaria
Pyronaridine‐artesunate (PY‐AS) may leads to lower total failure: day 28 (unadjusted) compared with artemether‐lumefantrine (AL) (low certainty).
2 findings from 1 review
Serious adverse events (42 days) · adults and children with uncomplicated P falciparum malaria
Pyronaridine‐artesunate (PY‐AS) showed no clear difference in serious adverse events (42 days) compared with artemether‐lumefantrine (AL) (low certainty).
1 finding from 1 review
First treatment, abnormal ALT increase (42 days) · adults and children with uncomplicated P falciparum malaria
Pyronaridine‐artesunate (PY‐AS) may leads to higher first treatment, abnormal ALT increase (42 days) compared with artemether‐lumefantrine (AL) (low certainty).
1 finding from 1 review
First treatment, abnormal AST increase (42 days) · adults and children with uncomplicated P falciparum malaria
Pyronaridine‐artesunate (PY‐AS) may leads to higher first treatment, abnormal AST increase (42 days) compared with artemether‐lumefantrine (AL) (low certainty).
1 finding from 1 review
First treatment, abnormal bilirubin increase (42 days) · adults and children with uncomplicated P falciparum malaria
Pyronaridine‐artesunate (PY‐AS) showed no clear difference in first treatment, abnormal bilirubin increase (42 days) compared with artemether‐lumefantrine (AL) (low certainty).
1 finding from 1 review
Uterine volume (cm³) · women with premature ovarian insufficiency (POI) awaiting oocyte donation
2 findings from 1 review
Endometrial thickness (mm) · women with premature ovarian insufficiency (POI) awaiting oocyte donation
2 findings from 1 review
Overall postoperative complications (within 30 days of operation) · women with gynaecological cancers
Enhanced recovery after surgery programme showed no clear difference in overall postoperative complications (within 30 days of operation) compared with traditional care (low certainty).
1 finding from 1 review
Mortality (within 30 days of discharge) · women with gynaecological cancers
It is very uncertain whether enhanced recovery after surgery programme changes mortality (within 30 days of discharge) compared with traditional care (very low certainty).
1 finding from 1 review
Patient readmissions · women with gynaecological cancers
Enhanced recovery after surgery programme may leads to lower readmission (within 30 days of operation) compared with traditional care (low certainty).
1 finding from 1 review
Duration of catheter patency (days; combining participant and catheter as unit of analysis) Blood withdrawing · adults with CVCs
1 finding from 1 review
Intervention not reported
Primary ‐ Short‐term complications (abscess, perforation, obstruction or fistula) within 30 days · Patients with acute uncomplicated diverticulitis
The intervention showed no clear difference in primary ‐ Short‐term complications (abscess, perforation,… (low certainty).
1 finding from 1 review
Intervention not reported
Primary ‐ Short‐term complications (abscess, perforation, obstruction or fistula) within 30 days · Patients with acute uncomplicated diverticulitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Primary ‐ Short‐term emergency surgery within 30 days · Patients with acute uncomplicated diverticulitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Primary ‐ Short‐term emergency surgery within 30 days · Patients with acute uncomplicated diverticulitis
The intervention showed no clear difference in primary ‐ Short‐term emergency surgery within 30 days (low certainty).
1 finding from 1 review
Intervention not reported
Primary ‐ Short‐term complications (abscess, perforation, obstruction or fistula) within 30 days · Patients with acute uncomplicated diverticulitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Primary ‐ Short‐term emergency surgery within 30 days · Patients with acute uncomplicated diverticulitis
The intervention showed no clear difference in primary ‐ Short‐term emergency surgery within 30 days (low certainty).
1 finding from 1 review
Hospital admissions: days of inpatient mental health care Timing of outcome assessment: 12 months · adults meeting 3 or more diagnostic criteria for borderline personality disorder
1 finding from 1 review